Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11393)
All Articles published online
|
Publishing Process of This Article
|
Jan 15, 2014 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ganepola GA, Rutledge JR, Suman P, Yiengpruksawan A, Chang DH. Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer. World J Gastrointest Oncol 2014; 6(1): 22-33 [PMID: 24578785 DOI: 10.4251/wjgo.v6.i1.22] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v6/i1/22.htm |
| Number | Citing Articles |
| 1 |
Margaret G Keane, Amar Shah, Stephen P Pereira, Deepak Joshi. Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy. F1000Research 2017; 6: 1643 doi: 10.12688/f1000research.11371.1
|
| 2 |
Thuy T. P. Nguyen, Kamrul Hassan Suman, Thong Ba Nguyen, Ha Thi Nguyen, Duy Ngoc Do. The Role of miR-29s in Human Cancers—An Update. Biomedicines 2022; 10(9): 2121 doi: 10.3390/biomedicines10092121
|
| 3 |
Jakub Wnuk, Joanna Katarzyna Strzelczyk, Iwona Gisterek. Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma–A Review of the Literature. International Journal of Molecular Sciences 2023; 24(6): 5113 doi: 10.3390/ijms24065113
|
| 4 |
Zhanyun Lv, Qiguang Shi, Wenhui Huang, Chunye Xing, Yanlei Hao, Xungang Feng, Yan Yang, Aimei Zhang, Qingxia Kong, Nobuhiro Yuki, Yuzhong Wang. MicroRNA expression profiling in Guillain-Barré syndrome. Journal of Neuroimmunology 2016; 301: 12 doi: 10.1016/j.jneuroim.2016.10.014
|
| 5 |
Ruirui Yang, Yun Fu, Ying Zeng, Mengqin Xiang, Yufang Yin, Li Li, Haifan Xu, Jing Zhong, Xi Zeng. Serum miR-20a is a promising biomarker for gastric cancer. Biomedical Reports 2017; 6(4): 429 doi: 10.3892/br.2017.862
|
| 6 |
Monica Valente, Alessia Covre, Anna Maria Di Giacomo, Michele Maio. Hepato-Pancreato-Biliary Malignancies. 2022; : 761 doi: 10.1007/978-3-030-41683-6_50
|
| 7 |
Imteyaz Ahmad Khan, Anoop Saraya. Circulating MicroRNAs as Noninvasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer: A Review. Journal of Gastrointestinal Cancer 2023; 54(3): 720 doi: 10.1007/s12029-022-00877-1
|
| 8 |
Hiromitsu Hayashi, Norio Uemura, Kazuki Matsumura, Liu Zhao, Hiroki Sato, Yuta Shiraishi, Yo-ichi Yamashita, Hideo Baba. Recent advances in artificial intelligence for pancreatic ductal adenocarcinoma. World Journal of Gastroenterology 2021; 27(43): 7480-7496 doi: 10.3748/wjg.v27.i43.7480
|
| 9 |
Andrew S. Day, Steven T. Leach, Daniel A. Lemberg. An update on diagnostic and prognostic biomarkers in inflammatory bowel disease. Expert Review of Molecular Diagnostics 2017; 17(9): 835 doi: 10.1080/14737159.2017.1364160
|
| 10 |
MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential. Genes 2019; 10(10): 752 doi: 10.3390/genes10100752
|
| 11 |
Natalia A. Gablo, Vladimir Prochazka, Zdenek Kala, Ondrej Slaby, Igor Kiss. Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer. Current Genomics 2020; 20(8): 569 doi: 10.2174/1389202921666191217095017
|
| 12 |
Neveen Abd El Moneim Hussein, Zenat A. El Kholy, Medhat M. Anwar, Mohamed A. Ahmad, Shaymaa M. Ahmad. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer. Journal of Cancer Research and Clinical Oncology 2017; 143(1): 83 doi: 10.1007/s00432-016-2248-7
|
| 13 |
Marta Fernandez‐Mercado, Lorea Manterola, Erika Larrea, Ibai Goicoechea, María Arestin, María Armesto, David Otaegui, Charles H. Lawrie. The circulating transcriptome as a source of non‐invasive cancer biomarkers: concepts and controversies of non‐coding and coding RNA in body fluids. Journal of Cellular and Molecular Medicine 2015; 19(10): 2307 doi: 10.1111/jcmm.12625
|
| 14 |
Moussa Ndiaye, Gora Diop, Celine Derbois, Jean-Louis Spadoni, Josselin Noirel, Raissa Medina‑Santos, Cedric Coulonges, Magali Torres, Alioune Dieye, Mbacke Sembene, Jean-François Deleuze, Alain Toledano, Ahmadou Dem, Jean-François Zagury, Sigrid Le Clerc. Gene expression profiling of peripheral blood mononuclear cells from women with cervical lesions reveals new markers of cancer. Oncology Reports 2023; 49(6) doi: 10.3892/or.2023.8555
|
| 15 |
Zhongyang Ding, Haorong Wu, Jiaming Zhang, Guorong Huang, Dongdong Ji. MicroRNAs as novel biomarkers for pancreatic cancer diagnosis: a meta-analysis based on 18 articles. Tumor Biology 2014; 35(9): 8837 doi: 10.1007/s13277-014-2133-4
|
| 16 |
Kazuharu Kai, Rachel L. Dittmar, Subrata Sen. Secretory microRNAs as biomarkers of cancer. Seminars in Cell & Developmental Biology 2018; 78: 22 doi: 10.1016/j.semcdb.2017.12.011
|
| 17 |
Logeeshan Velmanickam, Manpreet Bains, Michael Fondakowski, Glenn Paul Dorsam, Dharmakeerthi Nawarathna. iLluminate-miRNA: Paradigm for high-throughput, low-cost, and sensitive miRNA detection in serum samples at point-of-care. Journal of Physics D: Applied Physics 2019; 52(5): 055401 doi: 10.1088/1361-6463/aaed97
|
| 18 |
Jennifer B. Permuth, Tania Mesa, Sion L. Williams, Yoslayma Cardentey, Dongyu Zhang, Erica A. Pawlak, Jiannong Li, Miles E. Cameron, Karla N. Ali, Daniel Jeong, Sean J. Yoder, Dung-Tsa Chen, Jose G. Trevino, Nipun Merchant, Mokenge Malafa, Kazufumi Honda. A pilot study to troubleshoot quality control metrics when assessing circulating miRNA expression data reproducibility across study sites. Cancer Biomarkers 2022; 33(4): 467 doi: 10.3233/CBM-210255
|
| 19 |
Andrea Russo, Rosario Caltabiano, Antonio Longo, Teresio Avitabile, Livio M. Franco, Vincenza Bonfiglio, Lidia Puzzo, Michele Reibaldi. Increased Levels of miRNA-146a in Serum and Histologic Samples of Patients with Uveal Melanoma. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00424
|
| 20 |
Yangbing Jin, Yuanchi Weng, Yue Wang, Jiewei Lin, Xiaxing Deng, Baiyong Shen, Qian Zhan, Xiongxiong Lu. <p>miR-934 as a Prognostic Marker Facilitates Cell Proliferation and Migration of Pancreatic Tumor by Targeting PROX1</p>. OncoTargets and Therapy 2020; : 3389 doi: 10.2147/OTT.S249662
|
| 21 |
Logeeshan Velmanickam, Dharmakeerthi Nawarathna, Brian M. Cullum, Eric S. McLamore, Douglas Kiehl. Electric fields assisted fluorescence enhancement for microRNA biomarker detection in serum samples: strategies for combating cancer, obesity and addiction to opioid. Smart Biomedical and Physiological Sensor Technology XVI 2019; : 15 doi: 10.1117/12.2520312
|
| 22 |
Zhikui Liu, Yufeng Wang, Changwei Dou, Liankang Sun, Qing Li, Liang Wang, Qiuran Xu, Wei Yang, Qingguang Liu, Kangsheng Tu. RETRACTED ARTICLE: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0717-3
|
| 23 |
Taisuke Imamura, Shuhei Komatsu, Daisuke Ichikawa, Tsutomu Kawaguchi, Mahito Miyamae, Wataru Okajima, Takuma Ohashi, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Ryo Morimura, Hisashi Ikoma, Kazuma Okamoto, Eigo Otsuji. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids. World Journal of Gastroenterology 2016; 22(25): 5627-5641 doi: 10.3748/wjg.v22.i25.5627
|
| 24 |
Bo Kong, Helmut Friess. Translational Pancreatic Cancer Research. Molecular and Translational Medicine 2020; : 97 doi: 10.1007/978-3-030-49476-6_6
|
| 25 |
Ivana Peran, Eveline E. Vietsch, Gai Yan, Anna T. Riegel, Anton Wellstein. Distinct Response of Circulating microRNAs to the Treatment of Pancreatic Cancer Xenografts with FGFR and ALK Kinase Inhibitors. Cancers 2022; 14(6): 1517 doi: 10.3390/cancers14061517
|
| 26 |
Vidura Jayasooriya, Nathaniel Johnson, Adam Bradley, Christopher Kotarsky, Lizzy Jepng’etich, Daniel Friesner, Sherri Stastny, Kyle J. Hackney, Dharmakeerthi Nawarathna. A Miniaturized MicroRNA Sensor Identifies Targets Associated with Weight Loss in a Diet and Exercise Intervention among Healthy Overweight Individuals. Sensors 2022; 22(18): 6758 doi: 10.3390/s22186758
|
| 27 |
Motohiro Kojima, Hiroko Sudo, Junpei Kawauchi, Satoko Takizawa, Satoshi Kondou, Hitoshi Nobumasa, Atsushi Ochiai, Ajay Goel. MicroRNA Markers for the Diagnosis of Pancreatic and Biliary-Tract Cancers. PLOS ONE 2015; 10(2): e0118220 doi: 10.1371/journal.pone.0118220
|
| 28 |
Zhen-bin Diao, Tian-xiao Sun, Yi Zong, Bo-chuan Lin, Yuan-sheng Xia. Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma. Journal of International Medical Research 2020; 48(12): 030006052096781 doi: 10.1177/0300060520967818
|
| 29 |
Beste Turanli, Esra Yildirim, Gizem Gulfidan, Kazim Yalcin Arga, Raghu Sinha. Current State of “Omics” Biomarkers in Pancreatic Cancer. Journal of Personalized Medicine 2021; 11(2): 127 doi: 10.3390/jpm11020127
|
| 30 |
Smaranda Belciug, Florin Gorunescu. Learning a single-hidden layer feedforward neural network using a rank correlation-based strategy with application to high dimensional gene expression and proteomic spectra datasets in cancer detection. Journal of Biomedical Informatics 2018; 83: 159 doi: 10.1016/j.jbi.2018.06.003
|
| 31 |
Horst Pick, Ana Catarina Alves, Horst Vogel. Single-Vesicle Assays Using Liposomes and Cell-Derived Vesicles: From Modeling Complex Membrane Processes to Synthetic Biology and Biomedical Applications. Chemical Reviews 2018; 118(18): 8598 doi: 10.1021/acs.chemrev.7b00777
|
| 32 |
Pedro Moutinho-Ribeiro, Rosa Coelho, Marc Giovannini, Guilherme Macedo. Pancreatic cancer screening: Still a delusion?. Pancreatology 2017; 17(5): 754 doi: 10.1016/j.pan.2017.07.001
|
| 33 |
Emmy Borgmästars, Hendrik Arnold de Weerd, Zelmina Lubovac-Pilav, Malin Sund. miRFA: an automated pipeline for microRNA functional analysis with correlation support from TCGA and TCPA expression data in pancreatic cancer. BMC Bioinformatics 2019; 20(1) doi: 10.1186/s12859-019-2974-3
|
| 34 |
Wojciech Jelski, Barbara Mroczko. Biochemical diagnostics of pancreatic cancer - Present and future. Clinica Chimica Acta 2019; 498: 47 doi: 10.1016/j.cca.2019.08.013
|
| 35 |
Karen Howe. MicroRNA Profiling. Methods in Molecular Biology 2017; 1509: 17 doi: 10.1007/978-1-4939-6524-3_3
|
| 36 |
Qiulan Chen, Lanju Yang, Yilei Xiao, Jianxin Zhu, Zhongmin Li. Circulating microRNA-182 in plasma and its potential diagnostic and prognostic value for pancreatic cancer. Medical Oncology 2014; 31(11) doi: 10.1007/s12032-014-0225-z
|
| 37 |
Jaehoon Lee, Hee Seung Lee, Soo Been Park, Chanyang Kim, Kahee Kim, Dawoon E. Jung, Si Young Song. Identification of Circulating Serum miRNAs as Novel Biomarkers in Pancreatic Cancer Using a Penalized Algorithm. International Journal of Molecular Sciences 2021; 22(3): 1007 doi: 10.3390/ijms22031007
|
| 38 |
Kaiyue Zhang, Wanxia Zhong, Wei-Ping Li, Zi-Jiang Chen, Cong Zhang. miR-15a-5p levels correlate with poor ovarian response in human follicular fluid. Reproduction 2017; 154(4): 483 doi: 10.1530/REP-17-0157
|
| 39 |
Konstantin Schlick, Dominik Kiem, Richard Greil. Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy—A Review of the Literature. Biomolecules 2021; 11(10): 1469 doi: 10.3390/biom11101469
|
| 40 |
Robert S O'Neill, Alina Stoita. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?. World Journal of Gastroenterology 2021; 27(26): 4045-4087 doi: 10.3748/wjg.v27.i26.4045
|
| 41 |
Logeeshan Velmanickam, David H Chang, Ganepola Ap Ganepola, Dharmakeerthi Nawarathna. Low-cost and Rapid micro-RNA Assay for Identification of Pancreactic Cancer. 2021 IEEE Research and Applications of Photonics in Defense Conference (RAPID) 2021; : 1 doi: 10.1109/RAPID51799.2021.9521412
|
| 42 |
Logeeshan Velmanickam, Dharmakeerthi Nawarathna. Recent progress in microRNA detection using integrated electric fields and optical detection methods. Frontiers in Lab on a Chip Technologies 2024; 3 doi: 10.3389/frlct.2024.1349384
|
| 43 |
Logeeshan Velmanickam, Vidura Jayasooriya, Madhava Sarma Vemuri, Umamaheswara Rao Tida, Dharmakeerthi Nawarathna. Universal Biosensor for Multiple Biomarker Detection for Medical Applications. 2020 IEEE Research and Applications of Photonics in Defense Conference (RAPID) 2020; : 1 doi: 10.1109/RAPID49481.2020.9195702
|
| 44 |
Daoqin Dou, Shaohua Yang, Yunzheng Lin, Jiren Zhang. An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma. Cancer Biomarkers 2018; 23(1): 79 doi: 10.3233/CBM-181420
|
| 45 |
Caterina Vicentini, Federica Calore, Giovanni Nigita, Paolo Fadda, Michele Simbolo, Nicola Sperandio, Claudio Luchini, Rita T. Lawlor, Carlo Maria Croce, Vincenzo Corbo, Matteo Fassan, Aldo Scarpa. Exosomal miRNA signatures of pancreatic lesions. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01287-y
|
| 46 |
Jennifer Permuth-Wey, Dung-Tsa Chen, William J. Fulp, Sean J. Yoder, Yonghong Zhang, Christina Georgeades, Kazim Husain, Barbara Ann Centeno, Anthony M. Magliocco, Domenico Coppola, Mokenge Malafa. Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas. Cancer Prevention Research 2015; 8(9): 826 doi: 10.1158/1940-6207.CAPR-15-0094
|
| 47 |
Xiao-Ran Long, Yao-Jun Zhang, Mei-Yin Zhang, Keng Chen, X.F Steven Zheng, Hui-Yun Wang. Identification of an 88-microRNA signature in whole blood for diagnosis of hepatocellular carcinoma and other chronic liver diseases. Aging 2017; 9(6): 1565 doi: 10.18632/aging.101253
|
| 48 |
Immune-Related Circulating miR-125b-5p and miR-99a-5p Reveal a High Recurrence Risk Group of Pancreatic Cancer Patients after Tumor Resection. Applied Sciences 2019; 9(22): 4784 doi: 10.3390/app9224784
|
| 49 |
Samer Alsidawi, Ehsan Malek, James Driscoll. MicroRNAs in Brain Metastases: Potential Role as Diagnostics and Therapeutics. International Journal of Molecular Sciences 2014; 15(6): 10508 doi: 10.3390/ijms150610508
|
| 50 |
Qing-Cai Meng, Wang-Wang Qiu, Zi-Qiang Wen, Hong-Cheng Wang, Ze-Zhi Shan, Zhou Yuan, Xin-Yu Huang. Novel Blood-based microRNA Biomarkers for Diagnosis of Pancreatic Cancer: A Meta-analysis. Tumori Journal 2015; 101(2): 199 doi: 10.5301/tj.5000240
|
| 51 |
Maria Diab, Irfana Muqbil, Ramzi Mohammad, Asfar Azmi, Philip Philip. The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma. Journal of Clinical Medicine 2016; 5(6): 59 doi: 10.3390/jcm5060059
|
| 52 |
Xiao Sun, Xiaobin Zhou, Yuan Zhang, Xiaoyan Zhu, Haihua Liu. Systematic Review and Meta-Analysis of Diagnostic Accuracy of miRNAs in Patients with Pancreatic Cancer. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/6292396
|
| 53 |
Lu Yang, Huanyu Ju, Yuan Mu, Chunrong Gu. Clinical Molecular Diagnostics. 2021; : 493 doi: 10.1007/978-981-16-1037-0_34
|
| 54 |
Zenglin Pei, Song-Mei Liu, Jing-Tao Huang, Xuan Zhang, Dong Yan, Qianlin Xia, Chunxia Ji, Weiping Chen, Xiaoyan Zhang, Jianqing Xu, Jin Wang. Clinically relevant circulating microRNA profiling studies in pancreatic cancer using meta-analysis. Oncotarget 2017; 8(14): 22616 doi: 10.18632/oncotarget.15148
|
| 55 |
Xiaohong Jiang, Dongxia Hou, Zhe Wei, Shasha Zheng, Yujing Zhang, Jing Li. Extracellular and intracellular microRNAs in pancreatic cancer: from early diagnosis to reducing chemoresistance. ExRNA 2019; 1(1) doi: 10.1186/s41544-019-0014-0
|
| 56 |
Ishtiaq Hussain, Mamoon Ur Rashid, Jamaluddin Saeed, Zarghoona Wajid, Deepika Sarvepalli, Effa Zahid, Sundas Jehanzeb, Sarfraz Ahmad. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 239 doi: 10.1007/978-981-15-5471-1_14
|
| 57 |
Matt T Cashmore, Aaron J McCann, Stephen J Wastling, Cormac McGrath, John Thornton, Matt G Hall. Clinical quantitative MRI and the need for metrology. The British Journal of Radiology 2021; 94(1120): 20201215 doi: 10.1259/bjr.20201215
|
| 58 |
Satyanarayana Rachagani, Muzafar A. Macha, Nicholas Heimann, Parthasarathy Seshacharyulu, Dhanya Haridas, Seema Chugh, Surinder K. Batra. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Advanced Drug Delivery Reviews 2015; 81: 16 doi: 10.1016/j.addr.2014.10.020
|
| 59 |
Huiyin Lan, Haiqi Lu, Xian Wang, Hongchuan Jin. MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/125094
|
| 60 |
Jing Xia, Daming Xu, Yuanling Qin, Faguang Wan, Yongwei Ren, Chaozhi Bu, Tianyu Li. Meta-analysis of the Prognostic Value of microRNA-22 in Leukemia Patients. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231212309
|
| 61 |
Marco Ragusa, Cristina Barbagallo, Luisa Statello, Rosario Caltabiano, Andrea Russo, Lidia Puzzo, Teresio Avitabile, Antonio Longo, Mario D Toro, Davide Barbagallo, Hadi Valadi, Cinzia Di Pietro, Michele Purrello, Michele Reibaldi. miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications. Cancer Biology & Therapy 2015; 16(9): 1387 doi: 10.1080/15384047.2015.1046021
|
| 62 |
Takahiro Kishikawa, Motoyuki Otsuka, Motoko Ohno, Takeshi Yoshikawa, Akemi Takata, Kazuhiko Koike. Circulating RNAs as new biomarkers for detecting pancreatic cancer. World Journal of Gastroenterology 2015; 21(28): 8527-8540 doi: 10.3748/wjg.v21.i28.8527
|
| 63 |
Tereza Halkova, Romana Cuperkova, Marek Minarik, Lucie Benesova. MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Diagnosis and Prognosis. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/892903
|
| 64 |
Jingyu Wang, Yuan Li, Meiman Ding, Honghe Zhang, Xiaoming Xu, Jinlong Tang. Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review). International Journal of Oncology 2017; 50(2): 345 doi: 10.3892/ijo.2016.3811
|
| 65 |
Wei Zhang, Wenjie Xia, Zhengye Lv, Chao Ni, Yin Xin, Liu Yang. Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?. Cellular Physiology and Biochemistry 2017; 41(2): 755 doi: 10.1159/000458736
|
| 66 |
Tatsuya Machida, Takaaki Tomofuji, Takayuki Maruyama, Toshiki Yoneda, Daisuke Ekuni, Tetsuji Azuma, Hisataka Miyai, Hirofumi Mizuno, Hironari Kato, Koichiro Tsutsumi, Daisuke Uchida, Akinobu Takaki, Hiroyuki Okada, Manabu Morita. miR-1246 and miR-4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer. Oncology Reports 2016; 36(4): 2375 doi: 10.3892/or.2016.5021
|
| 67 |
Guangji Wang, Ningjiang Shen, Liang Cheng, Jianping Lin, Kanghua Li. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma. Tumor Biology 2015; 36(10): 7891 doi: 10.1007/s13277-015-3379-1
|
| 68 |
Lucy Oldfield, Rohith Rao, Lawrence N Barrera, Eithne Costello. Pancreatic Cancer. 2017; : 1 doi: 10.1007/978-1-4939-6631-8_86-1
|
| 69 |
Michal Eid, Paraskevi Karousi, Lumír Kunovský, Štěpán Tuček, Dagmar Brančíková, Zdeněk Kala, Ondřej Slabý, Jiří Mayer, Christos K. Kontos, Jan Trna. The Role of Circulating MicroRNAs in Patients with Early-Stage Pancreatic Adenocarcinoma. Biomedicines 2021; 9(10): 1468 doi: 10.3390/biomedicines9101468
|
| 70 |
Logeeshan Velmanickam, Rounak Pokharel, Ivan T. Lima, Dharmakeerthi Nawarathna. Label Free MicroRNA Biomarker Detection in Serum Samples for Diagnosis Applications at Point-of Care. 2019 IEEE Research and Applications of Photonics in Defense Conference (RAPID) 2019; : 1 doi: 10.1109/RAPID.2019.8864379
|
| 71 |
Smaranda Belciug. Logistic regression paradigm for training a single-hidden layer feedforward neural network. Application to gene expression datasets for cancer research. Journal of Biomedical Informatics 2020; 102: 103373 doi: 10.1016/j.jbi.2019.103373
|
| 72 |
Jonathan Rice, Henry Roberts, Shesh N. Rai, Susan Galandiuk. Housekeeping genes for studies of plasma microRNA: A need for more precise standardization. Surgery 2015; 158(5): 1345 doi: 10.1016/j.surg.2015.04.025
|
| 73 |
Beata Smolarz, Adam Durczyński, Hanna Romanowicz, Piotr Hogendorf. The Role of microRNA in Pancreatic Cancer. Biomedicines 2021; 9(10): 1322 doi: 10.3390/biomedicines9101322
|
| 74 |
Bin Huang, Chang Xin, Huanjun Yan, Zhewei Yu.
A Machine Learning Method for a Blood Diagnostic Model of Pancreatic Cancer Based on microRNA Signatures
. Critical Reviews in Immunology 2024; 44(3): 13 doi: 10.1615/CritRevImmunol.2023051250
|
| 75 |
Attila A. Seyhan. Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer—Advances and Challenges. International Journal of Molecular Sciences 2023; 24(17): 13340 doi: 10.3390/ijms241713340
|
| 76 |
Lunshou Wei, Kunhou Yao, Shibao Gan, Zhimin Suo. Clinical utilization of serum- or plasma-based miRNAs as early detection biomarkers for pancreatic cancer. Medicine 2018; 97(35): e12132 doi: 10.1097/MD.0000000000012132
|
| 77 |
Zhuqing Gao, Wei Jiang, Shutian Zhang, Peng Li. The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma. Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/9419072
|
| 78 |
Lucy Oldfield, Rohith Rao, Lawrence N. Barrera, Eithne Costello. Pancreatic Cancer. 2018; : 1241 doi: 10.1007/978-1-4939-7193-0_86
|
| 79 |
Beata Smolarz, Adam Durczyński, Hanna Romanowicz, Krzysztof Szyłło, Piotr Hogendorf. miRNAs in Cancer (Review of Literature). International Journal of Molecular Sciences 2022; 23(5): 2805 doi: 10.3390/ijms23052805
|
| 80 |
SHOULI WANG, JIKAI YIN, TAO LI, LIJUAN YUAN, DONG WANG, JIAXING HE, XILIN DU, JIANGUO LU. Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma. Oncology Reports 2015; 33(2): 819 doi: 10.3892/or.2014.3641
|
| 81 |
Wen Wen, Shi-Juan Mai, Huan-Xin Lin, Mei-Yin Zhang, Jia-Ling Huang, Xin Hua, Chao Lin, Zhi-Qing Long, Zi-Jian Lu, Xiao-Qing Sun, Sai-Lan Liu, Qi Yang, Qian Zhu, Hui-Yun Wang, Ling Guo. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-1923-2
|
| 82 |
Jonathan Rice, Henry Roberts, James Burton, Jianmin Pan, Vanessa States, Shesh N. Rai, Susan Galandiuk, Jörg D. Hoheisel. Assay Reproducibility in Clinical Studies of Plasma miRNA. PLOS ONE 2015; 10(4): e0121948 doi: 10.1371/journal.pone.0121948
|
| 83 |
Tsutomu Kawaguchi, Shuhei Komatsu, Daisuke Ichikawa, Masahiro Tsujiura, Hiroki Takeshita, Shoji Hirajima, Mahito Miyamae, Wataru Okajima, Takuma Ohashi, Taisuke Imamura, Jun Kiuchi, Hirotaka Konishi, Atsushi Shiozaki, Kazuma Okamoto, Eigo Otsuji. Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers. International Journal of Molecular Sciences 2016; 17(9): 1459 doi: 10.3390/ijms17091459
|
| 84 |
Zeeshan Sattar, Saeed Ali, Ishtiaq Hussain, Farhan Sattar, Sana Hussain, Sarfraz Ahmad. Theranostic Approach for Pancreatic Cancer. 2019; : 51 doi: 10.1016/B978-0-12-819457-7.00002-5
|
| 85 |
Monica Valente, Alessia Covre, Anna Maria Di Giacomo, Michele Maio. Hepato-Pancreato-Biliary Malignancies. 2021; : 1 doi: 10.1007/978-3-030-37482-2_50-1
|
| 86 |
Nicolas Vigneron, Matthieu Meryet-Figuière, Audrey Guttin, Jean-Paul Issartel, Bernard Lambert, Mélanie Briand, Marie-Hélène Louis, Mégane Vernon, Pierre Lebailly, Yannick Lecluse, Florence Joly, Sophie Krieger, Stéphanie Lheureux, Bénédicte Clarisse, Alexandra Leconte, Pascal Gauduchon, Laurent Poulain, Christophe Denoyelle. Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy. Molecular Oncology 2016; 10(7): 981 doi: 10.1016/j.molonc.2016.03.005
|
| 87 |
Logeeshan Velmanickam, David H Chang, Ganepola AP Ganepola, Dharmakeerthi Nawarathna. microRNA Detection in Heathy and Pancreatic Cancer Samples. 2023 IEEE Research and Applications of Photonics in Defense Conference (RAPID) 2023; : 1 doi: 10.1109/RAPID54473.2023.10264765
|
| 88 |
Chengfei Zhao, Feng Gao, Shaohuang Weng, Qicai Liu. Pancreatic cancer and associated exosomes. Cancer Biomarkers 2017; 20(4): 357 doi: 10.3233/CBM-170258
|
| 89 |
Cancer Simulation from Stage Minus One by Quantum microRNA Language: Lung, Colorectal and Pancreatic Cancers. Med One 2019; doi: 10.20900/mo.20190023
|
| 90 |
Oskar Franklin, Pär Jonsson, Ola Billing, Erik Lundberg, Daniel Öhlund, Hanna Nyström, Christina Lundin, Henrik Antti, Malin Sund. Plasma Micro-RNA Alterations Appear Late in Pancreatic Cancer. Annals of Surgery 2018; 267(4): 775 doi: 10.1097/SLA.0000000000002124
|
| 91 |
Nivaldo Faria Vieira, Luciano Neder Serafini, Paulo Cezar Novais, Fermino Sanches Lizarte Neto, Mucio Luiz de Assis Cirino, Rafael Kemp, José Celso Ardengh, Fabiano Pinto Saggioro, Alberto Facury Gaspar, Ajith Kumar Sankarankutty, Jorge Resende Lopes Júnior, Daniela Pretti da Cunha Tirapelli, José Sebastião dos Santos. The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis. Oncotarget 2021; 12(17): 1638 doi: 10.18632/oncotarget.28038
|
| 92 |
Petra Vychytilova-Faltejskova, Ondrej Slaby. Circulating microRNAs in Disease Diagnostics and their Potential Biological Relevance. Experientia Supplementum 2015; 106: 75 doi: 10.1007/978-3-0348-0955-9_4
|
| 93 |
Kennichi Satoh. Molecular Approaches Using Body Fluid for the Early Detection of Pancreatic Cancer. Diagnostics 2021; 11(2): 375 doi: 10.3390/diagnostics11020375
|